Drugs becoming eligible for first Paragraph IV ANDA filing in 2030
Drugs expiring in 2031
Drugs that contains Benoxinate Hydrochloride; Fluorescein Sodium
Verona Pharma patents expiration
Drugs that contains Cobicistat
Drugs that contains Dolutegravir Sodium
Drugs that contains Vorasidenib
Mallinckrodt Ireland patents expiration
